bluebird bio, Inc. Insider Trading for June 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for June 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 50.51 | 3,430 | 173,249 | 6,270 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 24.47 | 1,298 | 31,762 | 1,216 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Option Exercise | M | 20.70 | 2,000 | 41,400 | 1,250 | |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 108.55 | 59 | 6,404 | 6,407 | 6.5 K to 6.4 K (-0.91 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 110.28 | 1,824 | 201,148 | 6,466 | 8.3 K to 6.5 K (-22.00 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 109.41 | 1,611 | 176,266 | 8,290 | 9.9 K to 8.3 K (-16.27 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Sell | S | 108.02 | 3,293 | 355,711 | 9,901 | 13.2 K to 9.9 K (-24.96 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 50.51 | 3,430 | 173,249 | 13,194 | 9.8 K to 13.2 K (+35.13 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 24.47 | 1,298 | 31,762 | 9,764 | 8.5 K to 9.8 K (+15.33 %) |
| Jun 30 2017 | BLUE | bluebird bio, Inc. | Sullivan Eric | Principal Accountin ... | Buy | M | 20.70 | 2,000 | 41,400 | 8,466 | 6.5 K to 8.5 K (+30.93 %) |
| Jun 29 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 108.53 | 11,288 | 1,225,026 | 349,368 | 360.7 K to 349.4 K (-3.13 %) |
| Jun 29 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 107.65 | 13,712 | 1,476,138 | 360,656 | 374.4 K to 360.7 K (-3.66 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 5.50 | 1,992 | 10,957 | 23,842 | |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,008 | 4,189 | 0 | |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 110.48 | 800 | 88,385 | 2,800 | 3.6 K to 2.8 K (-22.22 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 109.74 | 1,000 | 109,740 | 3,600 | 4.6 K to 3.6 K (-21.74 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 108.29 | 2,200 | 238,237 | 4,600 | 6.8 K to 4.6 K (-32.35 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 5.50 | 1,992 | 10,957 | 6,800 | 4.8 K to 6.8 K (+41.43 %) |
| Jun 27 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,008 | 4,189 | 4,808 | 2.8 K to 4.8 K (+71.71 %) |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,500 | 5,216 | 2,008 | |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 120.03 | 2,500 | 300,070 | 2,800 | 5.3 K to 2.8 K (-47.17 %) |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,500 | 5,216 | 5,300 | 2.8 K to 5.3 K (+89.29 %) |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 110.05 | 850 | 93,545 | 32,484 | 33.3 K to 32.5 K (-2.55 %) |
| Jun 22 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 109.01 | 2,445 | 266,540 | 33,334 | 35.8 K to 33.3 K (-6.83 %) |
| Jun 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 2,500 | 5,216 | 10,236 | |
| Jun 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 111.10 | 2 | 222 | 27,305 | 27.3 K to 27.3 K (-0.01 %) |
| Jun 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 110.42 | 579 | 63,931 | 27,307 | 27.9 K to 27.3 K (-2.08 %) |
| Jun 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 109.27 | 1,919 | 209,679 | 27,886 | 29.8 K to 27.9 K (-6.44 %) |
| Jun 14 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 2,500 | 5,216 | 29,805 | 27.3 K to 29.8 K (+9.16 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Vachon Mark | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 3,176 | 2.2 K to 3.2 K (+45.96 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MARAGANORE JOHN | Director | Grant | A | 0.00 | 1,000 | 0 | 5,843 | 4.8 K to 5.8 K (+20.65 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Mandell James | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,500 | 5,216 | 4,508 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | A | 111.00 | 5,600 | 621,600 | 5,600 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 110.20 | 2,500 | 275,488 | 2,800 | 5.3 K to 2.8 K (-47.17 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,500 | 5,216 | 5,300 | 2.8 K to 5.3 K (+89.29 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Grant | A | 0.00 | 1,400 | 0 | 2,800 | 1.4 K to 2.8 K (+100.00 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | DIXON WENDY L | Director | Grant | A | 0.00 | 1,000 | 0 | 2,000 | 1,000 to 2 K (+100.00 %) |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Option Exercise | A | 111.00 | 10,700 | 1,187,700 | 10,700 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | MELTON DOUGLAS | Director | Grant | A | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Option Exercise | A | 111.00 | 10,700 | 1,187,700 | 10,700 | |
| Jun 12 2017 | BLUE | bluebird bio, Inc. | Agwunobi John O | Director | Grant | A | 0.00 | 2,700 | 0 | 2,700 | 0 to 2.7 K |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 2.09 | 2,500 | 5,216 | 12,736 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 100.05 | 2,500 | 250,135 | 27,305 | 29.8 K to 27.3 K (-8.39 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 2.09 | 2,500 | 5,216 | 29,805 | 27.3 K to 29.8 K (+9.16 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 2,263 | 4,722 | 7,008 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 100.14 | 2,263 | 226,622 | 1,400 | 3.7 K to 1.4 K (-61.78 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 2,263 | 4,722 | 3,663 | 1.4 K to 3.7 K (+161.64 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,000 | 50,510 | 29,500 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 99.04 | 1,500 | 148,560 | 35,779 | 37.3 K to 35.8 K (-4.02 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,000 | 50,510 | 37,279 | 36.3 K to 37.3 K (+2.76 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 50.51 | 435 | 21,972 | 13,500 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 50.51 | 1,740 | 87,887 | 13,935 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Option Exercise | M | 22.53 | 15,070 | 339,527 | 36,812 | |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 100.05 | 435 | 43,522 | 15,801 | 16.2 K to 15.8 K (-2.68 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 50.51 | 435 | 21,972 | 16,236 | 15.8 K to 16.2 K (+2.75 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Sell | S | 100.22 | 16,810 | 1,684,705 | 15,801 | 32.6 K to 15.8 K (-51.55 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 50.51 | 1,740 | 87,887 | 32,611 | 30.9 K to 32.6 K (+5.64 %) |
| Jun 08 2017 | BLUE | bluebird bio, Inc. | Cole Jason | Chief Legal Officer | Buy | M | 22.53 | 15,070 | 339,527 | 30,871 | 15.8 K to 30.9 K (+95.37 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Option Exercise | M | 2.09 | 1,000 | 2,086 | 9,271 | |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Sell | S | 90.00 | 1,000 | 90,002 | 1,400 | 2.4 K to 1.4 K (-41.67 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | LYNCH DANIEL | Director | Buy | M | 2.09 | 1,000 | 2,086 | 2,400 | 1.4 K to 2.4 K (+71.43 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 1,000 | 2,090 | 9,239 | |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 90.00 | 1,000 | 90,002 | 17,177 | 18.2 K to 17.2 K (-5.50 %) |
| Jun 07 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 1,000 | 2,090 | 18,177 | 17.2 K to 18.2 K (+5.82 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 750 | 37,883 | 30,500 | |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 76.00 | 400 | 30,400 | 36,279 | 36.7 K to 36.3 K (-1.09 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 75.48 | 1,100 | 83,030 | 36,679 | 37.8 K to 36.7 K (-2.91 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 750 | 37,883 | 37,779 | 37 K to 37.8 K (+2.03 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 2.09 | 2,000 | 4,180 | 10,239 | |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 75.42 | 2,000 | 150,849 | 17,177 | 19.2 K to 17.2 K (-10.43 %) |
| Jun 05 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 2.09 | 2,000 | 4,180 | 19,177 | 17.2 K to 19.2 K (+11.64 %) |